H.R. 5376 · 119th Congress · Health

Impacts and Outcomes for Health Career Training Act

In committee202 words Introduced Sep 16, 2025 · Latest action Sep 16, 2025

How far it has goneStage 2 of 6
  1. IntroducedSep 16, 2025 Done
  2. CommitteeReferred to Ways and Means Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Full text

No CRS summary yet · 202 words

H.R. 5376 · Introduced in House · Sep 16, 2025

SECTION 1. SHORT TITLE.

This Act may be cited as the Impacts and Outcomes for Health Career Training Act .

SEC. 2. EVIDENCE-BASED FUNDING APPROACH TO STUDY THE EFFECTS OF HEALTH PROFESSION OPPORTUNITY GRANT DEMONSTRATION PROJECTS; EVALUATION OF DEMONSTRATION PROJECTS.

Section 2008 of the Social Security Act ( 42 U.S.C. 1397g ) is amended— by redesignating subsections (c) and (d) as subsections (d) and (e), respectively; and by inserting after subsection (b) the following:

(c) Study. (1) In general The Secretary shall conduct a study of the short-, medium-, and long-term impacts of the demonstration projects for which a grant is made under this section, including the employment and earnings of project participants. (2) Funding The Secretary shall use not less than 4 percent of total amount made available to carry out this section for each fiscal year for the study required by paragraph (1), evaluations, and associated staffing, for the purpose of supporting the rigorous evaluation of the demonstration projects, and supporting the continued study of the short-, medium-, and long-term effects of all such projects, including the effectiveness of new or added elements of the demonstration projects.

SEC. 3. EFFECTIVE DATE.

The amendments made by this Act shall take effect on October 1, 2025.

Shown here because the text is under 500 words. Open on Congress.gov

Who lobbies on it

37 organizations, more than 99% of House bills · 134 filings · Q3 2025–Q3 2026

The sponsor got money from 13 of these 37 organizations’ PACs in the 2025–26 election cycle.

See which of these PACs gave to the sponsor, and how much → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Pharmaceutical Research and Manufacturers of America 5 of 5 quarters
    “Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542…”

    $26.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  2. Eli Lilly and Company 5 of 5 quarters
    “Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial…”

    $9.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  3. Gilead Sciences, Inc. 5 of 5 quarters
    “Implementation H.R.5376 - Inflation Reduction Act of 2022. Issues around drug pricing.”

    $7.1M lobbying spend in 2026 to date, all issuesQ3 2026 filing

34 more organizations, every filingPROUpgrade

Organizations that named H.R. 5376 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Sep 16, 2025Referred to the House Committee on Ways and Means.
  2. Sep 16, 2025Introduced in House